Abstract:K.A.C. Elliott and I submitted a paper (1) to the 1943 Federation Meeting in Cleveland, subsequently cancelled because of wartime exigencies. It was one of a series of studies of brain metabolism by Elliott, Libet, and McNair Scott in the early b940s. I was then a young postdoctoral physiologist with Elliott at the Institute of the Pennsylvania Hospital, before he went to McGill University to spend the next 30-44) years of his distinguished career as a neurochemist. After some war-related research on clothing and survival problems I resumed (in 1945) my primary interests in neuroand electrophysiology (begun earlier with R. W. Gerard); but my time with Elliott gave me invaluable experience in neurochemistry and in rigorous, carefully controlled experimentation. We had demonstrated that homogenized suspensions of rat brain in isotonic media respired at rates comparable to those of brain slices (2). That led to the use of such suspensions for quantitative studies of the oxidation of endogenous and added substrates by brain tissue (3). Among other things, additon of glucose or pyruvate largely suppressed the oxidation of endogenous non-carbohydrate substrates. In theabsence of added glucose, noncarbohydrate oxidation supported respiratory rates at about 50% those with glucose; even these rates fell off sharply after the first 1-2 hours, presumably as available substrate was depleted or as some inhibitory end product accumulated. Added glycogen also stimulated brain respiration, but later on we found that more purified glycogen did not do this and pointed to an impurity asthe agent. That impurity turned out to be iron,in a form bound to a protein obtainable from liver(4).We named it “ferrin.” In a partially purified form it contained b5 % of iron soluble at neutral or even alkaline pH. Ferrin differed from femtin (5) in its absence from horse spleen (the richest source of ferritin) and in certain solubility characteristics. Ido not know whether a physiological role for ferrin was ever established, but it seemed to have potential interest asa form of soluble liver iron and even as a contaminant in certain liver products (as we found with glycogen). The substrates and catalysts in noncarbohydrate oxidation by brain tissue were of considerable interest, especially for events during hypoglycemic shock and seizures induced by insulin. Panimon et al. (6) had reported that iron salts increased the rateof oxygen uptake by brain and other tissues, probably via the oxidation of phospholipids and proteins. We then found that the combined addition of very small amounts of iron and ascorbic acid (b mM) produced a large increase in oxygen uptake by isotonic brain (or liver) suspensions (b, 7). This was accompanied by no change in CO2 evolution. With purified mixed phospholipid from brain or liver, ascorbic acid plus iron compounds produced a very rapid oxidation. Only the cephalic fraction of brain phospholipd was oxidized. Ascorbate or iron alone were only weakly active; other reducing agents could not replace ascorbate; inorganic iron salts were as effective as ferrim, but the latter had the advantage of being soluble at body pH values. Epinephrine inhibited the effectsof iron and ascorbic acid, while certain amino acids facilitated them. All this led to the speculative possibility that iron-protein compounds together with ascorbate may have a role in normal phospholipid metabolism and could thereby affect membrane permeability characteristics. The additional finding, that the oxygen uptake by /ypotonic brain suspensions was greatly stimulated by iron plus ascorbate so as to rise to values almost equal to that of isotonic suspensions, seemed to support the notion of membrane-phospholipid oxidation. That is, disruption of membranes of the cells and their subcellular structures by the hypotonic medium would make such phospholipid-contasning structures more accessible to the iron-ascorbate action. It was also interesting that this action was heat-resistant and did not require the enzymatic catalyses that mediate carbohydrate oxidation (see also ref 6). If

A qualitative study to explore psychological distress and illness burden associated with opioid-induced constipation in cancer patients with advanced disease

Gestational buprenorphine exposure: Effects on pregnancy, development, neonatal opioid withdrawal syndrome, and behavior in a translational rodent model

Brain Metabolism, “Ferrin,” and Non‐Carbohydrate Oxidation

Molecular and Long-Term Behavioral Consequences of Neonatal Opioid Exposure and Withdrawal in Mice.

Prenatal buprenorphine/naloxone exposure and neonatal neurobehavioral functioning: A preliminary report

Peripartum buprenorphine and oxycodone exposure impair maternal behavior and increase neuroinflammation in the brains of new mother rats

Maternal exposure to buprenorphine, but not methadone, during pregnancy reduces social play behavior across two generations of offspring

Neurobehavioral outcomes of infants exposed to buprenorphine-naloxone compared with naltrexone during pregnancy

Prenatal heroin exposure alters brain morphology and connectivity in adolescent mice

Hiccup during anaesthesia.

Abnormal morphology and synaptogenic signaling in astrocytes following prenatal opioid exposure

Differences in withdrawal symptoms, microglia activity, and cognitive functioning in rats exposed to continuous low-dose heroin in-utero

Comparative Safety of In Utero Exposure to Buprenorphine Combined With Naloxone vs Buprenorphine Alone

Buprenorphine Induces Human Fetal Membrane Sterile Inflammation

Buprenorphine and methadone differentially alter early brain development in human cortical organoids

Decreased myelin-related gene expression in the nucleus accumbens during spontaneous neonatal opioid withdrawal in the absence of long-term behavioral effects in adult outbred CFW mice

Unexpected pyomyositis of right buttock.

Neurobehavioral Characterization of Perinatal Oxycodone-Exposed Offspring in Early Adolescence

Prenatal methadone exposure and child developmental outcomes in 2-year-old children

Maternal care behavior and physiology moderate offspring outcomes following gestational exposure to opioids